["Protein cancers" hypothesis for neurodegenerative diseases]. 2011

Masato Hasegawa
Department of Neuropathology and Cell Biology, Tokyo Metropolitan Institute of Medical Science.

Intracellular filamentous inclusions composed of amyloid-like proteins are common neuropathological features of many neurodegenerative disorders. Although the extent of the abnormal protein pathologies is closely correlated with the disease progression, little attention has been given to the molecular mechanisms to explain how these pathological proteins spread. We developed a novel method for introducing amyloid seeds into cells, and presented experimental evidence of seed-dependent polymerization, leading to the formation of filamentous protein deposits and cell death. Overexpression of alpha-synuclein itself does not generate abnormal inclusions, but if fibril seeds are introduced, abundant alpha-synuclein inclusions positive for PSer129 and ubiquitin are developed, and the cells undergo cell death. This was also clearly demonstrated in cells expressing different tau isoforms by introducing the corresponding tau fibril seeds. These results obtained from biochemical analyses of abnormal proteins in patients strongly suggest that amyloid-like proteins, including tau, alpha-synuclein and TDP-43, propagate from cell to cell and this propagation is the cause of disease progression, analogously to metastasis of cancer cells to multiple different tissues in cancer progression. From this point of view, I have proposed as a hypothesis that neurodegenerative diseases with amyloid-like proteins can be regarded as "protein cancers".

UI MeSH Term Description Entries
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000682 Amyloid A fibrous protein complex that consists of proteins folded into a specific cross beta-pleated sheet structure. This fibrillar structure has been found as an alternative folding pattern for a variety of functional proteins. Deposits of amyloid in the form of AMYLOID PLAQUES are associated with a variety of degenerative diseases. The amyloid structure has also been found in a number of functional proteins that are unrelated to disease. Amyloid Fibril,Amyloid Fibrils,Amyloid Substance,Fibril, Amyloid,Fibrils, Amyloid,Substance, Amyloid
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease
D019636 Neurodegenerative Diseases Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures. Degenerative Diseases, Nervous System,Degenerative Diseases, Central Nervous System,Degenerative Diseases, Neurologic,Degenerative Diseases, Spinal Cord,Degenerative Neurologic Diseases,Degenerative Neurologic Disorders,Nervous System Degenerative Diseases,Neurodegenerative Disorders,Neurologic Degenerative Conditions,Neurologic Degenerative Diseases,Neurologic Diseases, Degenerative,Degenerative Condition, Neurologic,Degenerative Conditions, Neurologic,Degenerative Neurologic Disease,Degenerative Neurologic Disorder,Neurodegenerative Disease,Neurodegenerative Disorder,Neurologic Degenerative Condition,Neurologic Degenerative Disease,Neurologic Disease, Degenerative,Neurologic Disorder, Degenerative,Neurologic Disorders, Degenerative

Related Publications

Masato Hasegawa
October 2011, Medical hypotheses,
Masato Hasegawa
November 2019, Brain and nerve = Shinkei kenkyu no shinpo,
Masato Hasegawa
January 2018, Medical hypotheses,
Masato Hasegawa
April 2014, Pharmacology & therapeutics,
Masato Hasegawa
January 2025, Neurodegenerative disease management,
Masato Hasegawa
March 2023, International journal of molecular sciences,
Masato Hasegawa
June 2004, Neuropathology and applied neurobiology,
Copied contents to your clipboard!